Lexapro Approved for Adolescent Depression
by abcnews.go.com
The Forest Laboratories antidepressant Lexapro (escitalopram oxalate) has been approved to treat major depressive disorder (MDD) in people aged 12 to 17, the company said Friday in a news release.
Some 2 million teens in the United States have had a bout of MDD in the past year, the company said.
Approved for adults in 2002, Lexapro is among a class of antidepressants called selective serotonin reuptake inhibitors (SSRIs). It was evaluated in treating adolescent depression in two placebo-controlled studies, the news release said.
According to the Associated Press, the U.S. Justice Department last month filed a complaint against Forest, alleging that the drug maker had inappropriately promoted Lexapro for use by children. Forest has denied the complaint's allegations, the wire service said.
Lexapro and similar antidepressants include an FDA "black-box" label warning stating they show an increased risk compared to a non-medicinal placebo of "suicidal thinking and behavior (suicidality) in children, adolescents, and young adults in short-term studies of major depressive disorder (MDD) and other psychiatric disorders."
The warning advises that anyone considering the use of Lexapro or any other antidepressant in a child, adolescent, or young adult "must balance this risk with the clinical need."
Source: http://abcnews.go.com/Health/Healthday/story?id=7135665
Find patient medical information how to buy Lexapro oral on http://corn-crake.tumblr.com/lexapro-escitalopram/. Order Lexapro, including Lexapro 10mg medication, from online pharmacy with free shipping on all orders of Lexapro and other discount.
Monday, June 1, 2026
Using Omnicef For Ear Infection: What Patients Should Know
Dealing with ear infection can take a real toll on daily life, affecting sleep, work performance, and overall well-being. While many people try to manage symptoms with lifestyle adjustments alone, medication often plays a central role in achieving meaningful relief, particularly when symptoms are moderate to severe or recurring. Different classes of antibiotics have different spectrums of activity and mechanisms of action. Penicillins and cephalosporins disrupt bacterial cell wall synthesis. Fluoroquinolones inhibit enzymes needed for DNA replication. Macrolides block bacterial protein production at the ribosome. Tetracyclines also inhibit protein synthesis through a different binding site. Each class is best suited to specific types of infections, and healthcare providers select antibiotics based on the most likely organisms causing a given infection. Healthcare professionals frequently discuss Omnicef as a potential treatment for patients presenting with ear infection. The data supporting omnicef for ear infection provides a useful resource for patients who want a thorough understanding of how this medication has been studied and what clinical experience suggests about its effectiveness. One of the practical considerations with Omnicef is timing. Some patients find that taking the medication at a consistent time each day helps maintain stable effects. Food interactions, if any, should be noted since they can affect how well the active ingredient cefdinir is absorbed. Patients are encouraged to review the full prescribing information or consult a pharmacist for personalized guidance. Treatment of ear infection does not always follow a one-size-fits-all approach. The antibiotic treatments section on antibiotic treatments covers the range of treatments that might complement or serve as alternatives to Omnicef, helping patients and providers find the combination most suited to individual needs.
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.